FAM222A, Part of the BET-Regulated Basal Endothelial Transcriptome, Is a Novel Determinant of Endothelial Biology and Angiogenesis.
Aspasia TzaniStefan HaemmigHenry S ChengDaniel Perez-CremadesMarina Augusto HeuschkelAnurag JamaiyarSasha A SinghMasanori AikawaPaul B YuTianxi WangSun YeMark W FeinbergJorge PlutzkyPublished in: Arteriosclerosis, thrombosis, and vascular biology (2023)
BET control over the basal endothelial transcriptome includes FAM222A, a novel, BRD4-regulated, key determinant of endothelial biology and angiogenesis.